Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
As of today, Johnson & Johnson(JNJ) shares are valued at $233.38. The company's market cap stands at 570.11B, with a P/E ratio of 20.91 and a dividend yield of 2.2%.
On 2026-02-03, Johnson & Johnson(JNJ) stock traded between a low of $230.06 and a high of $235.20. Shares are currently priced at $233.38, which is +1.4% above the low and -0.8% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 9.32M, against a daily average of 10.18M.
During the past year, Johnson & Johnson(JNJ) stock moved between $141.50 at its lowest and $235.20 at its peak.
During the past year, Johnson & Johnson(JNJ) stock moved between $141.50 at its lowest and $235.20 at its peak.
JNJ News
RBC Capital raised the firm’s price target on Johnson & Johnson to $255 from $240 and keeps an Outperform rating on the shares. The company is unlikely to undo...
Johnson & Johnson recently reported fourth-quarter 2025 sales of US$24,564 million and full-year 2025 sales of US$94,193 million, alongside FDA approval of DARZ...
Johnson & Johnson (JNJ) is back in focus after a run of upbeat news, including strong fourth quarter and full year 2025 results, fresh 2026 sales guidance, and...
Analyst ratings
57%
of 28 ratingsMore JNJ News
Insiders have been trading these 5 stocks: ((GOOG)), ((INTC)), ((MU)), ((JNJ)) and ((ADBE)). Here is a breakdown of their recent trades and their value. Claim 5...
FDA approved expanded use of DARZALEX FASPRO combination therapy for newly diagnosed multiple myeloma patients ineligible for stem cell transplant. A long runn...
Johnson & Johnson is a picture of stability. Johnson & Johnson (JNJ 0.02%), a leading healthcare giant, has been around for over 100 years and has achieved a l...
Some Johnson & Johnson ( ) shareholders may be a little concerned to see that the CEO & Chairman, Joaquin Duato, recently sold a substantial US$22m worth of sto...
Investors in Johnson & Johnson (Symbol: JNJ) saw new options become available today, for the March 13th expiration. At Stock Options Channel , our YieldBoost fo...
Johnson & Johnson (JNJ) CEO Joaquin Duato has sold a major block of company stock just days after the healthcare giant reported mixed fourth-quarter results. Ac...
Johnson & Johnson (NYSE:JNJ) received FDA approval for DARZALEX FASPRO in a new combination therapy for newly diagnosed multiple myeloma patients who are inelig...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.